An interventional study of Testes shocker in Infertility, Male, Infertility Unexplained and Infertility Due to Complete Spermatogenic Arrest, sponsored by University of Baghdad. Status unknown at 1 site in Iraq. Open to male participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-03.
Sponsored by University of Baghdad · Not applicable, Interventional, and Treatment
Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.
This study demonstrated that using a painless, convenient at-home device could significantly improve sperm motility and count. This device can be utilized to tackle (for unexplained infertility) the significant issue of infertility in a cost-effective, safe and efficacious.
282 studies on the registry are indexed under Infertility, Male; 65 are open to participants now.
This study's planned enrollment of 250 is above the median of 80 across 187 interventional studies indexed under Infertility, Male.
Browse Infertility, Male studies →University of Baghdad is the lead sponsor of 170 studies on the registry; 69 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This device is working and giving the electrical shocks regularly.
Device: Testes shocker
This device is not giving electricity but it is working with a red light, so the participants cannot suspect it.
Device: Testes shocker
It is a device that give electric shocks (up to 5 milli Amperes) and it is designed to contain both the testes within it.
Semen analysis
By taking the semen from the participants at baseline and then after each month and analyse it.
Time frame: 4 months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.